| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,915 |
6,682 |
$267K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,521 |
3,607 |
$199K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
202 |
184 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
820 |
671 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
297 |
248 |
$6K |
| 90756 |
|
254 |
235 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
4,096 |
3,504 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
416 |
369 |
$4K |
| 80305 |
|
827 |
646 |
$4K |
| 90686 |
|
451 |
385 |
$4K |
| 92552 |
|
242 |
201 |
$4K |
| 81003 |
|
2,549 |
2,135 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
381 |
340 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
391 |
221 |
$3K |
| 96160 |
|
323 |
262 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
162 |
128 |
$1K |
| 96127 |
|
355 |
284 |
$1K |
| 99173 |
|
275 |
224 |
$750.55 |
| 90661 |
|
26 |
24 |
$616.09 |
| 96161 |
|
143 |
112 |
$536.50 |
| 97802 |
|
12 |
12 |
$136.31 |
| 85018 |
|
81 |
58 |
$107.19 |
| 36416 |
|
175 |
114 |
$61.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
31 |
27 |
$11.15 |
| 99000 |
|
46 |
44 |
$0.00 |
| 94760 |
|
23 |
13 |
$0.00 |